547 related articles for article (PubMed ID: 22895942)
21. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
22. Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.
Ede CJ; Nikolova D; Brand M
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011717. PubMed ID: 30073663
[TBL] [Abstract][Full Text] [Related]
23. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2017 May; 5(5):CD001939. PubMed ID: 28518283
[TBL] [Abstract][Full Text] [Related]
24. Variceal band ligation versus beta-blockers for primary prevention of variceal bleeding: a meta-analysis.
Tripathi D; Graham C; Hayes PC
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):835-45. PubMed ID: 17873606
[TBL] [Abstract][Full Text] [Related]
25. Ursodeoxycholic acid for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
[TBL] [Abstract][Full Text] [Related]
26. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410
[TBL] [Abstract][Full Text] [Related]
27. Tranexamic acid for upper gastrointestinal bleeding.
Bennett C; Klingenberg SL; Langholz E; Gluud LL
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006640. PubMed ID: 25414987
[TBL] [Abstract][Full Text] [Related]
28. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding.
Funakoshi N; Duny Y; Valats JC; Ségalas-Largey F; Flori N; Bismuth M; Daurès JP; Blanc P
Ann Hepatol; 2012; 11(3):369-83. PubMed ID: 22481457
[TBL] [Abstract][Full Text] [Related]
30. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.
Colli A; Gana JC; Yap J; Adams-Webber T; Rashkovan N; Ling SC; Casazza G
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008759. PubMed ID: 28444987
[TBL] [Abstract][Full Text] [Related]
31. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D supplementation for prevention of cancer in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Krstic G; Wetterslev J; Gluud C
Cochrane Database Syst Rev; 2014 Jun; (6):CD007469. PubMed ID: 24953955
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis.
Gonzalez R; Zamora J; Gomez-Camarero J; Molinero LM; Bañares R; Albillos A
Ann Intern Med; 2008 Jul; 149(2):109-22. PubMed ID: 18626050
[TBL] [Abstract][Full Text] [Related]
34. Tranexamic acid for upper gastrointestinal bleeding.
Gluud LL; Klingenberg SL; Langholz E
Cochrane Database Syst Rev; 2012 Jan; 1():CD006640. PubMed ID: 22258969
[TBL] [Abstract][Full Text] [Related]
35. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.
Sarin SK; Lamba GS; Kumar M; Misra A; Murthy NS
N Engl J Med; 1999 Apr; 340(13):988-93. PubMed ID: 10099140
[TBL] [Abstract][Full Text] [Related]
36. Bezafibrate for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
[TBL] [Abstract][Full Text] [Related]
37. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients.
D'Amico G; Pagliaro L; Pietrosi G; Tarantino I
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD002233. PubMed ID: 20238318
[TBL] [Abstract][Full Text] [Related]
38. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
40. Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
Bai M; Qi X; Yang M; Han G; Fan D
J Gastroenterol Hepatol; 2014 Mar; 29(3):442-52. PubMed ID: 24118091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
